 Elizabeth Gillespie
Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disinfection | 7 | 2017 | 131 | 2.280 |
Why?
| | Infection Control | 12 | 2016 | 174 | 2.190 |
Why?
| | Housekeeping, Hospital | 5 | 2019 | 6 | 2.180 |
Why?
| | Cross Infection | 11 | 2022 | 261 | 2.140 |
Why?
| | Disease Outbreaks | 8 | 2017 | 420 | 1.450 |
Why?
| | Equipment Contamination | 6 | 2016 | 67 | 1.400 |
Why?
| | Environmental Microbiology | 4 | 2015 | 47 | 1.320 |
Why?
| | Decontamination | 2 | 2016 | 28 | 0.920 |
Why?
| | Steam | 5 | 2017 | 14 | 0.870 |
Why?
| | Health Facilities | 3 | 2015 | 85 | 0.870 |
Why?
| | Sterilization | 2 | 2014 | 24 | 0.810 |
Why?
| | Safety-net Providers | 1 | 2024 | 132 | 0.770 |
Why?
| | Intensive Care Units | 4 | 2015 | 928 | 0.760 |
Why?
| | Hot Temperature | 2 | 2024 | 396 | 0.730 |
Why?
| | Operating Rooms | 2 | 2015 | 145 | 0.730 |
Why?
| | Allergists | 1 | 2022 | 13 | 0.710 |
Why?
| | Climate Change | 4 | 2026 | 187 | 0.700 |
Why?
| | Gram-Positive Bacterial Infections | 3 | 2017 | 72 | 0.650 |
Why?
| | Environmental Exposure | 1 | 2024 | 583 | 0.610 |
Why?
| | Vancomycin-Resistant Enterococci | 2 | 2017 | 9 | 0.610 |
Why?
| | Australia | 7 | 2017 | 299 | 0.530 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 895 | 0.520 |
Why?
| | Cost-Benefit Analysis | 3 | 2016 | 653 | 0.510 |
Why?
| | Duodenoscopes | 1 | 2016 | 7 | 0.490 |
Why?
| | Public Health | 1 | 2022 | 577 | 0.490 |
Why?
| | Disease Transmission, Infectious | 1 | 2017 | 69 | 0.480 |
Why?
| | Luminescent Measurements | 1 | 2016 | 75 | 0.470 |
Why?
| | Medical Waste Disposal | 1 | 2016 | 3 | 0.470 |
Why?
| | Enterobacteriaceae Infections | 1 | 2016 | 43 | 0.470 |
Why?
| | Bedding and Linens | 1 | 2016 | 11 | 0.470 |
Why?
| | Maintenance and Engineering, Hospital | 1 | 2015 | 1 | 0.440 |
Why?
| | Durable Medical Equipment | 1 | 2015 | 5 | 0.440 |
Why?
| | Bacteremia | 3 | 2022 | 222 | 0.440 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 223 | 0.410 |
Why?
| | Patient Isolation | 1 | 2014 | 20 | 0.410 |
Why?
| | Disposable Equipment | 1 | 2014 | 24 | 0.410 |
Why?
| | Adenosine Triphosphate | 1 | 2016 | 500 | 0.400 |
Why?
| | Silver | 1 | 2014 | 36 | 0.400 |
Why?
| | Disinfectants | 1 | 2014 | 45 | 0.390 |
Why?
| | Fluorescent Dyes | 2 | 2014 | 342 | 0.390 |
Why?
| | Staphylococcal Infections | 3 | 2022 | 395 | 0.390 |
Why?
| | Anti-Infective Agents | 1 | 2016 | 234 | 0.380 |
Why?
| | Perioperative Nursing | 1 | 2013 | 3 | 0.380 |
Why?
| | Environmental Monitoring | 1 | 2015 | 347 | 0.380 |
Why?
| | Hair | 1 | 2013 | 84 | 0.370 |
Why?
| | Sutures | 1 | 2013 | 66 | 0.360 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 334 | 0.350 |
Why?
| | Drug Therapy | 1 | 2012 | 84 | 0.350 |
Why?
| | Hand Disinfection | 3 | 2013 | 24 | 0.350 |
Why?
| | Health Personnel | 2 | 2015 | 762 | 0.330 |
Why?
| | Reference Standards | 1 | 2011 | 177 | 0.330 |
Why?
| | Bacterial Infections | 1 | 2012 | 247 | 0.320 |
Why?
| | Victoria | 8 | 2022 | 22 | 0.310 |
Why?
| | Nurses | 1 | 2012 | 171 | 0.310 |
Why?
| | Guideline Adherence | 3 | 2008 | 590 | 0.280 |
Why?
| | Humans | 38 | 2026 | 147293 | 0.280 |
Why?
| | Methicillin Resistance | 2 | 2008 | 17 | 0.270 |
Why?
| | Bacteria | 1 | 2014 | 769 | 0.270 |
Why?
| | Medical Staff, Hospital | 2 | 2008 | 80 | 0.270 |
Why?
| | Equipment Reuse | 1 | 2007 | 18 | 0.270 |
Why?
| | Endoscopes | 1 | 2007 | 17 | 0.270 |
Why?
| | Chlorhexidine | 1 | 2007 | 24 | 0.250 |
Why?
| | Serratia Infections | 1 | 2007 | 8 | 0.250 |
Why?
| | Anti-Infective Agents, Local | 1 | 2007 | 41 | 0.250 |
Why?
| | Serratia marcescens | 1 | 2007 | 17 | 0.250 |
Why?
| | Clostridium Infections | 2 | 2022 | 74 | 0.250 |
Why?
| | Homes for the Aged | 3 | 2017 | 33 | 0.240 |
Why?
| | Nursing Staff, Hospital | 2 | 2008 | 145 | 0.240 |
Why?
| | Influenza, Human | 2 | 2014 | 634 | 0.240 |
Why?
| | Staphylococcus aureus | 3 | 2022 | 458 | 0.230 |
Why?
| | Environmental Health | 1 | 2026 | 43 | 0.230 |
Why?
| | Endoscopy | 1 | 2007 | 322 | 0.220 |
Why?
| | Attitude of Health Personnel | 2 | 2012 | 1220 | 0.190 |
Why?
| | Education, Medical, Undergraduate | 1 | 2026 | 208 | 0.190 |
Why?
| | Carrier State | 2 | 2015 | 79 | 0.190 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1940 | 0.190 |
Why?
| | Quality of Health Care | 1 | 2007 | 697 | 0.180 |
Why?
| | Extreme Heat | 1 | 2022 | 9 | 0.180 |
Why?
| | Time Factors | 4 | 2016 | 7173 | 0.180 |
Why?
| | International Classification of Diseases | 1 | 2022 | 151 | 0.170 |
Why?
| | Curriculum | 2 | 2026 | 1082 | 0.170 |
Why?
| | Colony Count, Microbial | 2 | 2014 | 90 | 0.170 |
Why?
| | Heat Stress Disorders | 1 | 2022 | 84 | 0.160 |
Why?
| | Internal Medicine | 1 | 2024 | 280 | 0.160 |
Why?
| | Societies, Medical | 1 | 2024 | 914 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2026 | 740 | 0.140 |
Why?
| | Safety Management | 1 | 2019 | 128 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2026 | 1121 | 0.130 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2016 | 5 | 0.120 |
Why?
| | Respirovirus Infections | 1 | 2016 | 14 | 0.120 |
Why?
| | Longitudinal Studies | 1 | 2024 | 3027 | 0.120 |
Why?
| | Stroke | 1 | 2026 | 1287 | 0.120 |
Why?
| | Textiles | 1 | 2017 | 22 | 0.120 |
Why?
| | Bacteriological Techniques | 1 | 2017 | 66 | 0.120 |
Why?
| | Medical Waste | 1 | 2016 | 2 | 0.120 |
Why?
| | Aged | 8 | 2024 | 26514 | 0.120 |
Why?
| | Gram-Positive Bacteria | 1 | 2016 | 48 | 0.120 |
Why?
| | Environment, Controlled | 1 | 2015 | 22 | 0.110 |
Why?
| | Gram-Negative Bacteria | 1 | 2016 | 80 | 0.110 |
Why?
| | Quality Control | 1 | 2015 | 161 | 0.110 |
Why?
| | Enterococcus faecium | 1 | 2015 | 22 | 0.110 |
Why?
| | Urinary Tract Infections | 1 | 2017 | 212 | 0.110 |
Why?
| | Enterococcus | 2 | 2011 | 22 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 617 | 0.100 |
Why?
| | Quality Improvement | 1 | 2022 | 1321 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1167 | 0.100 |
Why?
| | Equipment and Supplies, Hospital | 1 | 2013 | 5 | 0.100 |
Why?
| | Masks | 1 | 2014 | 70 | 0.100 |
Why?
| | Caliciviridae Infections | 1 | 2013 | 18 | 0.100 |
Why?
| | Norovirus | 1 | 2013 | 22 | 0.100 |
Why?
| | Floors and Floorcoverings | 1 | 2012 | 4 | 0.090 |
Why?
| | Enterobacteriaceae | 1 | 2013 | 44 | 0.090 |
Why?
| | Drug Resistance, Microbial | 1 | 2013 | 67 | 0.090 |
Why?
| | Infant, Newborn | 3 | 2017 | 6543 | 0.090 |
Why?
| | Gastroenteritis | 1 | 2013 | 63 | 0.090 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 98 | 0.090 |
Why?
| | Professional Competence | 1 | 2012 | 91 | 0.090 |
Why?
| | Ultraviolet Rays | 1 | 2014 | 385 | 0.090 |
Why?
| | Catheterization, Peripheral | 1 | 2013 | 120 | 0.090 |
Why?
| | Polymers | 1 | 2015 | 486 | 0.090 |
Why?
| | Education, Medical, Continuing | 1 | 2012 | 134 | 0.080 |
Why?
| | Staining and Labeling | 1 | 2011 | 153 | 0.080 |
Why?
| | Escherichia coli Infections | 1 | 2011 | 125 | 0.080 |
Why?
| | Hospitals | 1 | 2016 | 740 | 0.080 |
Why?
| | Environment | 1 | 2012 | 297 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2024 | 17560 | 0.080 |
Why?
| | Male | 11 | 2024 | 73950 | 0.080 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 185 | 0.080 |
Why?
| | Pilot Projects | 2 | 2014 | 1912 | 0.080 |
Why?
| | Middle Aged | 5 | 2024 | 36821 | 0.080 |
Why?
| | Adolescent | 3 | 2024 | 22825 | 0.080 |
Why?
| | Nursing Homes | 1 | 2011 | 174 | 0.080 |
Why?
| | Female | 10 | 2024 | 80076 | 0.070 |
Why?
| | Child, Preschool | 1 | 2024 | 12016 | 0.070 |
Why?
| | Young Adult | 2 | 2024 | 14437 | 0.070 |
Why?
| | Health Services Research | 1 | 2011 | 392 | 0.070 |
Why?
| | Influenza Vaccines | 1 | 2014 | 541 | 0.070 |
Why?
| | Skin Care | 1 | 2008 | 22 | 0.070 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2015 | 302 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2015 | 976 | 0.070 |
Why?
| | Infectious Disease Transmission, Professional-to-Patient | 1 | 2008 | 5 | 0.070 |
Why?
| | Adult | 4 | 2024 | 41405 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2946 | 0.060 |
Why?
| | Delivery of Health Care | 2 | 2022 | 951 | 0.050 |
Why?
| | Cultural Competency | 1 | 2026 | 91 | 0.050 |
Why?
| | Vaccination | 1 | 2014 | 1443 | 0.050 |
Why?
| | Risk Factors | 4 | 2026 | 11017 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2026 | 177 | 0.050 |
Why?
| | Seasons | 1 | 2007 | 540 | 0.050 |
Why?
| | Electronic Health Records | 2 | 2022 | 1214 | 0.050 |
Why?
| | Prevalence | 2 | 2026 | 2889 | 0.050 |
Why?
| | Practice Guidelines as Topic | 2 | 2008 | 1598 | 0.050 |
Why?
| | Diagnosis-Related Groups | 1 | 2022 | 35 | 0.050 |
Why?
| | United States | 3 | 2026 | 16313 | 0.050 |
Why?
| | Health Status Disparities | 1 | 2026 | 324 | 0.050 |
Why?
| | Critical Care | 1 | 2008 | 705 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2014 | 196 | 0.050 |
Why?
| | Arizona | 1 | 2022 | 81 | 0.050 |
Why?
| | Risk Assessment | 2 | 2026 | 3784 | 0.040 |
Why?
| | Education, Medical | 1 | 2024 | 277 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 556 | 0.030 |
Why?
| | Aged, 80 and over | 3 | 2016 | 8430 | 0.030 |
Why?
| | Pneumonia | 1 | 2022 | 636 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 70 | 0.030 |
Why?
| | Incidence | 2 | 2013 | 2954 | 0.030 |
Why?
| | Multilocus Sequence Typing | 1 | 2015 | 16 | 0.030 |
Why?
| | Drug Utilization | 1 | 2016 | 171 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 254 | 0.030 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 74 | 0.030 |
Why?
| | Genome, Bacterial | 1 | 2015 | 123 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 6164 | 0.030 |
Why?
| | Population Surveillance | 1 | 2017 | 486 | 0.030 |
Why?
| | Carbapenems | 1 | 2013 | 28 | 0.020 |
Why?
| | beta-Lactamases | 1 | 2013 | 54 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2013 | 50 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 780 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2013 | 330 | 0.020 |
Why?
| | Immunization Programs | 1 | 2014 | 194 | 0.020 |
Why?
| | beta-Lactam Resistance | 1 | 2011 | 10 | 0.020 |
Why?
| | Vancomycin Resistance | 1 | 2011 | 16 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2013 | 367 | 0.020 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 77 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1875 | 0.020 |
Why?
| | Medical Audit | 1 | 2008 | 77 | 0.020 |
Why?
| | Gram-Negative Aerobic Bacteria | 1 | 2008 | 3 | 0.020 |
Why?
| | Hospital Units | 1 | 2008 | 32 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 23 | 0.020 |
Why?
| | Infant | 1 | 2015 | 10194 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 8164 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 6011 | 0.010 |
Why?
|
|
Gillespie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|